The newest deal comes from Saventic Health based in Warsaw.
👯 Founder(s): Szymon Piątkowski (CEO) and Professor Grzegorz Basak
📅 Founding year: 2019
🏭 Industry: Health
💥 Problem: Many rare diseases go undiagnosed or are diagnosed too late due to insufficient resources or expertise to analyze complex patient data effectively.
📣 Solution: Saventic Health develops AI algorithms to analyze medical records and provide early diagnoses for rare diseases, significantly improving speed and accuracy.
👥 Customers: Doctors, clinics, and hospitals seeking enhanced diagnostic capabilities for rare diseases.
🌱 Stage: Growth
💰 Investment amount: €2 million in bridge funding
🚀 Funded by: 4growth VC (Poland); NCBR Investment Fund (Poland) and TNI Fund (USA)
💡 It will be spent on… Expanding operations in Europe, Canada, and South America, targeting new markets such as Austria, Sweden, Spain, and Italy, and enhancing their partnerships in South America.
💪 Their specialty: Saventic Health’s AI algorithms are designed to identify over 50 common rare diseases using medical records, laboratory tests, radiology, and other descriptive data. These algorithms are registered as medical devices in the EU and are faster, more cost-effective, and significantly more accurate than existing methods.
🔑 Business model: Licensing their Saventic Med Platform with AI-driven algorithms to hospitals and clinics, or charging for diagnostic services integrated into existing health systems.
📊 Traction: Active partnerships with 30+ clinics and hospitals in Poland, Germany, France, Brazil, and a centralized health system operator in Canada.
📈 Funding so far: €2.1 million in 2022 (from 4growth VC).
